Natco Gets SC Nod to Launch Generic Risdiplam at 80% Lower Price, Roche Appeal Dismissed Parthika Patel18 Oct 2025 7:14 PM ISTNew Delhi: The Supreme Court has given the go-ahead to Natco Pharma for launching its generic version of Risdiplam in India, dismissing the appeal...
Roche Moves SC Against Delhi HC Nod to Natco's Rs 15,900 Generic Risdiplam for Spinal Atrophy Parthika Patel16 Oct 2025 7:44 PM ISTNew Delhi: In a major escalation of the patent battle over a life-saving rare disease drug, Swiss pharmaceutical giant F. Hoffmann-La Roche AG has...
Delhi HC Dismisses Roche Appeal, Allows Natco to Continue Selling Generic Risdiplam for Spinal Muscular Atrophy Susmita Roy11 Oct 2025 9:41 PM ISTNew Delhi: The Delhi High Court has dismissed an appeal filed by Swiss drug major F. Hoffmann-La Roche AG and its Indian arm, challenging the order of...
Roche Evrysdi tablet gets European Commission approval for Spinal Muscular Atrophy Ruchika Sharma5 Jun 2025 2:00 PM ISTBasel: Roche has announced that the European Commission (EC) has approved a label extension for Evrysdi (risdiplam) to include a new,...
Risdiplam Price Disparity in India vs China, Pakistan: SC Issues Notice to Roche Farhat Nasim6 April 2025 2:00 PM ISTIt was submitted that why can't the Indian government negotiate with Roche to make the medicine for the rare disorder available at a cheaper rate.
Setback to Roche: Plea Against Natco on Risdiplam Patent Rejected by Delhi HC Farhat Nasim25 March 2025 5:31 PM ISTNew Delhi: In a major relief to Indian drugmaker Natco Pharma, the Delhi High Court has rejected an interim injunction plea filed by Swiss...
USFDA Approves Roche's Evrysdi Tablet for Spinal Muscular Atrophy Farhat Nasim15 Feb 2025 10:45 AM ISTEvrysdi is the only non-invasive disease-modifying treatment for SMA.
Rare Disease Patient Registry, Treatment Clinic soon in Kerala Kajal Rajput26 Jan 2025 1:30 PM ISTThiruvananthapuram: The Kerala government is planning to launch a registry for rare diseases and set up a treatment clinic in Kozhikode, State...
Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children, young adults with spinal muscular atrophy Ruchika Sharma31 Dec 2024 4:16 PM ISTBasel: Novartis has announced positive topline results from the Phase III STEER study. This pivotal study assessed the efficacy and safety of...
Natco Pharma submits application with USFDA for Risdiplam for Oral Solution Ruchika Sharma26 Nov 2024 3:21 PM ISTHyderabad: Natco Pharma, an Indian pharmaceutical company has announced the submission of an Abbreviated New Drug Application (ANDA)...
Plea for Urgent Financial Aid for Girl with Rare Disease: Delhi HC seeks Centre's reply Kajal Rajput26 Nov 2024 12:39 PM ISTNew Delhi: The Delhi High Court on Monday sought the Centre’s response regarding a plea filed by the mother of a young girl suffering...
KIMSHEALTH Doctors perform posterior scoliosis correction surgery on 23-year-old Maldivian Kajal Rajput20 Nov 2024 3:00 PM ISTThiruvananthapuram: Mohamad Raishan Ahmed, son of Ahmed Muhamad and Aminath Ibrahim, was born with Spinal Muscular Atrophy (SMA) type 2, a rare...
